Newer Therapies Will Steer Type 2 Diabetes Market in South-East Asia to $2.7 Billion by 2022; Finds New Report
The South-East Asian Type 2 Diabetes Mellitus (T2DM) market, which includes South Korea, Singapore, Taiwan, Malaysia, the Philippines, Thailand, Vietnam and Indonesia, will rise from $1.7 billion in 2015 to $2.7 billion by 2022, at a compound annual growth rate of 7.1%, according to research.
View full press release